149 related articles for article (PubMed ID: 15595873)
1. Fast monolithic micellar liquid chromatography: an alternative drug permeability assessing method for high-throughput screening.
Detroyer A; Stokbroekx S; Bohets H; Lorreyne W; Timmerman P; Verboven P; Massart DL; Vander Heyden Y
Anal Chem; 2004 Dec; 76(24):7304-9. PubMed ID: 15595873
[TBL] [Abstract][Full Text] [Related]
2. Evaluating "fast" micellar monolithic liquid chromatography for high-throughput quantitative structure-retention relationship screening.
Detroyer A; Vander Heyden Y; Reynaert K; Massart DL
Anal Chem; 2004 Apr; 76(7):1903-8. PubMed ID: 15053650
[TBL] [Abstract][Full Text] [Related]
3. QSAR study on permeability of hydrophobic compounds with artificial membranes.
Fujikawa M; Nakao K; Shimizu R; Akamatsu M
Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
[TBL] [Abstract][Full Text] [Related]
4. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
Usansky HH; Sinko PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
[TBL] [Abstract][Full Text] [Related]
5. [Biopartitioning micellar chromatography: its application in evaluating drug membrane transport and activity].
Mao JJ; Sun J; He ZG
Yao Xue Xue Bao; 2005 Oct; 40(10):865-70. PubMed ID: 16408799
[No Abstract] [Full Text] [Related]
6. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.
Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P
Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612
[TBL] [Abstract][Full Text] [Related]
8. Higher-throughput screening for Caco-2 permeability utilizing a multiple sprayer liquid chromatography/tandem mass spectrometry system.
Fung EN; Chu I; Li C; Liu T; Soares A; Morrison R; Nomeir AA
Rapid Commun Mass Spectrom; 2003; 17(18):2147-52. PubMed ID: 12955746
[TBL] [Abstract][Full Text] [Related]
9. Concurrent determination of topotecan and model permeability markers (atenolol, antipyrine, propranolol and furosemide) by reversed phase liquid chromatography: utility in Caco-2 intestinal absorption studies.
Bansal T; Singh M; Mishra G; Talegaonkar S; Khar RK; Jaggi M; Mukherjee R
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(2):261-6. PubMed ID: 17936093
[TBL] [Abstract][Full Text] [Related]
10. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
[TBL] [Abstract][Full Text] [Related]
11. Passive oral drug absorption can be predicted more reliably by experimental than computational models--fact or myth.
Linnankoski J; Ranta VP; Yliperttula M; Urtti A
Eur J Pharm Sci; 2008 Jul; 34(2-3):129-39. PubMed ID: 18455374
[TBL] [Abstract][Full Text] [Related]
12. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
Kotecha J; Shah S; Rathod I; Subbaiah G
Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Caco-2 cell monolayer drug transport properties by cassette dosing using UV/fluorescence HPLC.
Palmgrén JJ; Mönkkönen J; Jukkola E; Niva S; Auriola S
Eur J Pharm Biopharm; 2004 Mar; 57(2):319-28. PubMed ID: 15018991
[TBL] [Abstract][Full Text] [Related]
14. Exploring the role of different drug transport routes in permeability screening.
Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
[TBL] [Abstract][Full Text] [Related]
15. Investigation of vesicle electrokinetic chromatography as an in vitro assay for the estimation of intestinal permeability of pharmaceutical drug candidates.
Pascoe RJ; Masucci JA; Foley JP
Electrophoresis; 2006 Feb; 27(4):793-804. PubMed ID: 16411277
[TBL] [Abstract][Full Text] [Related]
16. An LD50 model for predicting psychotropic drug toxicity using biopartitioning micellar chromatography.
Quiñones-Torrelo C; Sagrado-Vives S; Villanueva-Camañas RM; Medina-Hernández MJ
Biomed Chromatogr; 2001 Feb; 15(1):31-40. PubMed ID: 11180298
[TBL] [Abstract][Full Text] [Related]
17. Prediction of human pharmacokinetics--gastrointestinal absorption.
Fagerholm U
J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
[TBL] [Abstract][Full Text] [Related]
18. Determination of selenium(IV) in pharmaceuticals and premixes by micellar liquid chromatography.
Kulikov AU
J Pharm Biomed Anal; 2007 Mar; 43(4):1283-9. PubMed ID: 17156959
[TBL] [Abstract][Full Text] [Related]
19. Biopartitioning micellar chromatography to predict skin permeability.
Martínez-Pla JJ; Martín-Biosca Y; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
Biomed Chromatogr; 2003 Dec; 17(8):530-7. PubMed ID: 14648611
[TBL] [Abstract][Full Text] [Related]
20. Experimental modelling of drug membrane permeability by capillary electrophoresis using liposomes, micelles and microemulsions.
Ornskov E; Gottfries J; Erickson M; Folestad S
J Pharm Pharmacol; 2005 Apr; 57(4):435-42. PubMed ID: 15831203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
